Eintrag weiter verarbeiten
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
Gespeichert in:
Zeitschriftentitel: | Journal for ImmunoTherapy of Cancer |
---|---|
Personen und Körperschaften: | , , , , , , , , , , , , , |
In: | Journal for ImmunoTherapy of Cancer, 3, 2015, S2 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
BMJ
|
Schlagwörter: |
author_facet |
Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S |
---|---|
author |
Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S |
spellingShingle |
Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S Journal for ImmunoTherapy of Cancer CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy |
author_sort |
morishima, chihiro |
spelling |
Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S 2051-1426 BMJ Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy http://dx.doi.org/10.1186/2051-1426-3-s2-p203 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Journal for ImmunoTherapy of Cancer |
doi_str_mv |
10.1186/2051-1426-3-s2-p203 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
imprint |
BMJ, 2015 |
imprint_str_mv |
BMJ, 2015 |
issn |
2051-1426 |
issn_str_mv |
2051-1426 |
language |
English |
mega_collection |
BMJ (CrossRef) |
match_str |
morishima2015citn1102interimtrialresultssubcutaneousadministrationofrecombinanthumanil15rhil15isassociatedwithexpansionofperipheralbloodcd56nkcellsandcd8tcells |
publishDateSort |
2015 |
publisher |
BMJ |
recordtype |
ai |
record_format |
ai |
series |
Journal for ImmunoTherapy of Cancer |
source_id |
49 |
title |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_unstemmed |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_full |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_fullStr |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_full_unstemmed |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_short |
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_sort |
citn11-02 interim trial results: subcutaneous administration of recombinant human il-15 (rhil-15) is associated with expansion of peripheral blood cd56+ nk cells and cd8+ t cells |
topic |
Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy |
url |
http://dx.doi.org/10.1186/2051-1426-3-s2-p203 |
publishDate |
2015 |
physical |
|
description |
|
container_issue |
S2 |
container_start_page |
0 |
container_title |
Journal for ImmunoTherapy of Cancer |
container_volume |
3 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792326729756311558 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:25:33.29Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=CITN11-02+interim+trial+results%3A+subcutaneous+administration+of+recombinant+human+IL-15+%28rhIL-15%29+is+associated+with+expansion+of+peripheral+blood+CD56%2B+NK+cells+and+CD8%2B+T+cells&rft.date=2015-12-01&genre=article&issn=2051-1426&volume=3&issue=S2&jtitle=Journal+for+ImmunoTherapy+of+Cancer&atitle=CITN11-02+interim+trial+results%3A+subcutaneous+administration+of+recombinant+human+IL-15+%28rhIL-15%29+is+associated+with+expansion+of+peripheral+blood+CD56%2B+NK+cells+and+CD8%2B+T+cells&aulast=Miller&aufirst=Jeffrey+S&rft_id=info%3Adoi%2F10.1186%2F2051-1426-3-s2-p203&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792326729756311558 |
author | Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S |
author_facet | Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S, Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S |
author_sort | morishima, chihiro |
container_issue | S2 |
container_start_page | 0 |
container_title | Journal for ImmunoTherapy of Cancer |
container_volume | 3 |
description | |
doi_str_mv | 10.1186/2051-1426-3-s2-p203 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz |
imprint | BMJ, 2015 |
imprint_str_mv | BMJ, 2015 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
issn | 2051-1426 |
issn_str_mv | 2051-1426 |
language | English |
last_indexed | 2024-03-01T12:25:33.29Z |
match_str | morishima2015citn1102interimtrialresultssubcutaneousadministrationofrecombinanthumanil15rhil15isassociatedwithexpansionofperipheralbloodcd56nkcellsandcd8tcells |
mega_collection | BMJ (CrossRef) |
physical | |
publishDate | 2015 |
publishDateSort | 2015 |
publisher | BMJ |
record_format | ai |
recordtype | ai |
series | Journal for ImmunoTherapy of Cancer |
source_id | 49 |
spelling | Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S 2051-1426 BMJ Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy http://dx.doi.org/10.1186/2051-1426-3-s2-p203 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Journal for ImmunoTherapy of Cancer |
spellingShingle | Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S, Journal for ImmunoTherapy of Cancer, CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells, Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy |
title | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_full | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_fullStr | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_full_unstemmed | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_short | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
title_sort | citn11-02 interim trial results: subcutaneous administration of recombinant human il-15 (rhil-15) is associated with expansion of peripheral blood cd56+ nk cells and cd8+ t cells |
title_unstemmed | CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells |
topic | Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy |
url | http://dx.doi.org/10.1186/2051-1426-3-s2-p203 |